Risk of Malignancy Index 3 (RMI3) Performance as a Predictor Advanced Stage Epithelial Ovarian Carcinoma used for NACT

Perfoma Risk of Malignancy Index 3 (RMI3) sebagai Prediktor Karsinoma Ovarium Epithelial Stadium Lanjut untuk Pertimbangan Pemberian NACT

Authors

  • Tatit Nurseta
  • Putu A. Herliawati student
  • Dhian E. P. Harnandari
  • Kusworini Handono
  • Yahya Irwanto
  • Sutrisno Sutrisno

DOI:

https://doi.org/10.32771/inajog.v10i1.1599

Downloads

Download data is not yet available.

Downloads

Published

2022-01-28

Versions

How to Cite

Nurseta, T., Herliawati, P. A., Harnandari, D. E. P., Handono, K., Irwanto, Y., & Sutrisno, S. (2022). Risk of Malignancy Index 3 (RMI3) Performance as a Predictor Advanced Stage Epithelial Ovarian Carcinoma used for NACT: Perfoma Risk of Malignancy Index 3 (RMI3) sebagai Prediktor Karsinoma Ovarium Epithelial Stadium Lanjut untuk Pertimbangan Pemberian NACT. Indonesian Journal of Obstetrics and Gynecology, 10(1), 42–48. https://doi.org/10.32771/inajog.v10i1.1599

Issue

Volume 10 No. 1 January 2022

Section

Research Article

Most read articles by the same author(s)